WHAT WE’RE READING – JOURNAL CLUB November 3, 2015July 28, 2016 Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Like Loading... Related
Penn Neurology - Division of Stroke and Vascular Neurology 